Cargando…
Novel Drug Delivery Strategies for the Treatment of Onychomycosis
Onychomycosis accounts for 50% of all nail disease cases and is commonly caused by dermatophytes. It was primarily considered a cosmetic problem but has been garnering attention lately due to its persistent nature and difficult treatment with relapses. With prolonged treatment duration and high cost...
Autores principales: | Dhamoon, Rupinder K., Popli, Harvinder, Gupta, Madhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691844/ https://www.ncbi.nlm.nih.gov/pubmed/31092174 http://dx.doi.org/10.2174/2211738507666190228104031 |
Ejemplares similares
-
Novel transungual drug delivery system for treating onychomycosis
por: Sharma, Sonal, et al.
Publicado: (2023) -
Novel and Investigational Treatments for Onychomycosis
por: Gregoriou, Stamatios, et al.
Publicado: (2022) -
Evaluation of the Drug Treatment and Persistence of Onychomycosis
por: Campbell, Andrew W., et al.
Publicado: (2004) -
Investigation on Utility of Some Novel Terpenes on Transungual Delivery of Terbinafine for the Management of Onychomycosis
por: Gupta, Isha, et al.
Publicado: (2022) -
Treatment of Onychomycosis: An Update
por: Shirwaikar, A. A., et al.
Publicado: (2008)